Stay updated on Baricitinib in Pediatric Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Baricitinib in Pediatric Atopic Dermatitis Clinical Trial page.

Latest updates to the Baricitinib in Pediatric Atopic Dermatitis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now displays a 403 Forbidden error screen instead of the usual study-record content, indicating an access restriction or outage rather than an update to the study data.SummaryDifference21%

- Check37 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, signaling a new build deployment for the ClinicalTrials.gov study details page.SummaryDifference0.0%

- Check44 days agoChange Detected- Added a funding/disclosure note: 2018 ( U.S. NIH Grant/Contract ) next to the study's identifiers in the Study Details. - This makes the funding source for the trial explicit within the registration context.SummaryDifference0.0%

- Check58 days agoChange DetectedCore study content is replaced with an error page, making the trial details and locations inaccessible. The page now shows an outage message, indicating the resource is temporarily unavailable.SummaryDifference20%

- Check73 days agoChange DetectedThe page’s revision label was updated from v3.6.3 to v3.6.4. This indicates a minor software update to the site interface rather than changes to study data.SummaryDifference0.0%

- Check94 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a new software release. This change does not appear to modify study details or visible content.SummaryDifference0.0%

Stay in the know with updates to Baricitinib in Pediatric Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Baricitinib in Pediatric Atopic Dermatitis Clinical Trial page.